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Abstract. The human intestinal epithelium is rapidly
and perpetually renewed as the descendants of multi-
potent stem cells located in crypts undergo prolifera-
tion, differentiation, and eventual exfoliation during a
very well organized migration along the crypt to villus
axis. The mechanisms that establish and maintain this
balance between proliferation and differentiation are
largely unknown. We have utilized HT29 cells, derived
from a human colon adenocarcinoma, as a model sys-
tem for identifying gene products that may regulate
these processes. Proliferating HT-29 cells cultured in
the absence of glucose (e.g., using inosine as the car-
bon source) have some of the characteristics of undif-
ferentiated but committed crypt epithelial cells while
postconfluent cells cultured in the absence of glucose
resemble terminally differentiated enterocytes or goblet
cells. A cDNA library, constructed from exponentially
growing HT-29 cells maintained in inosine-containing
media, was sequentially screened with a series of probes
depleted of sequences encoding housekeeping func-
tions and enriched for intestine-specific sequences that
are expressed in proliferating committed, but not dif-
ferentiated, epithelial cells. Of 100,000 recombinant
phage surveyed, one was found whose cDNA was de-
rived from an apparently gut-specific mRNA. It en-
codes a 316 residue, 35,463-D protein that is a new
member of the annexin/lipocortin family. Other family
members have been implicated in regulation of cellular
growth and in signal transduction pathways. RNA blot
T
HE intestinal epitheliumis composed of four principal
terminally differentiated cell types (reviewed in Neutra
et al., 1983): (a) absorptive cells or enterocYtes : b)
mucus-producing goblet cells; (c) a complex population of
enteroendocrine cells; and (d) Paneth cells that synthesize
lysozyme plus defensins (Ouellette et al ., 1989) and have
been postulated to form a component of the physical/bio-
chemical barrier that prevents bacterial translocation across
the gut. This epitheliumundergoes continuous and rapid re-
newal. Studies using normal (Winton et al ., 1988, 1989;
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and in situ hybridization studies indicate that the gene
encoding this new annexin exhibits region-specific ex-
pression along both axes of the human gut: (a) highest
levels of mRNA are present in the jejunum with marked
and progressive reductions occurring distally; (b) its
mRNA appears in crypt-associated epithelial cells and
increases in concentration as they exit the crypt. Villus-
associated epithelial cells continue to transcribe this
gene during their differentiation/translocation up the
villus. Immunocytochemical studies reveal that the in-
testine-specific annexin (ISA) is associated with the
plasma membrane of undifferentiated, proliferating
crypt epithelial cells as well as differentiated villus en-
terocytes. In polarized enterocytes, the highest concen-
trations of ISA are found at the apical compared to
basolateral membrane. In vitro studies using an octa-
peptide derived from residues 2-9 of the primary trans-
lation product of ISA mRNA and purified myristoyl-
CoA:protein N-myristoyltransferase suggested that it is
N-myristoylated. In vivo labeling studies confirmed
that myristate is covalently attached to ISA via a hy-
droxylamine resistant amide linkage. The restricted
cellular expression and acylation of ISA distinguish it
from other known annexins. The paradigm used to
identify and characterize this gene product from HT-29
cells should be generally applicable for defining other
sequences that may regulate proliferation and differen-
tiation in the human gut epithelium.
Winton and Ponder, 1990; Griffiths et al., 1988), chimeric
(Schmidt et al., 1985b, 1988, 1990 ; Ponder et al ., 1985) and
transgenic mice (Sweetser et al., 1988a,b; Cohn et al., 1991;
Roth et al., 1991b) suggest that a single, active multipotent
stem cell, located near the base ofeach intestinalcrypt, sus-
tains this renewal-giving rise to descendants that undergo
amplification (Porten and Loefer, 1990), commitment, and
differentiation into each of the four cell types (Cheng and
Leblond, 1974; Ponder et al ., 1985) . Proliferation is re-
stricted to the mid-crypt region where -150 ofthe 250 cells
405in each (mouse) small intestinal crypt pass through the cell
cycle every 12 h (Potten and Loeffler, 1990). Gut epithelial
cell differentiation occurs during a remarkably well-orga-
nized, bipolar migration (Schmidt et al., 1985a,b). Entero-
cytes, goblet cells, and enteroendocrine cells differentiate as
they migrate in vertical, coherent bands from the crypt up-
ward to an "extrusion" zone located at or near the villus tip.
Migration/differentiation/exfoliation is completed in ti3 d in
the mouse and in ti5 d in humans (reviewed in Potten and
Loeffier, 1990). In contrast, Paneth cellsdifferentiate during
a downward migration to the crypt base where _they have a
residence time of -4 wk in humans.
The intestinal epithelium thus is able to establish and
maintain a precise balance between proliferation and differ-
entiation. It represents an attractive model system for study-
ing these processes since they are rapid and perpetual, in-
volve a monoclonal population of cells (i.e., derived from a
single, ultimate stem cell; Winton et al., 1988,1989 ; Winton
and Ponder, 1990; Roth et al., 1991b), and occurin an easily
defined anatomic space.
The intestine is also able to establish and maintain spatial
differentiation alongits duodenal-to-colonic axis. For exam-
ple, the number of goblet cells and the distribution of en-
teroendocrine cell subpopulations vary as a function of loca-
tion along the cephalocaudal axis of the gut (Neutra, 1983 ;
Roth et al., 1990). Studies with intestinal isografts suggest
that the gut'sstem cell population may be programmed to re-
tain spatial memory before maturation of the crypt-tovillus
axis (Rubin et al ., 1991). Thus,gut stem cellsmay be charac-
terized by their seemingly enormous proliferative potential
(insuring both self-renewal and renewal ofthe epithelium) as
well as their ability to retain positional information.
Such a spatially well-organized system invites a number of
questions. First, what factors regulate proliferation and
differentiation? Second, to what extent are the processes of
proliferation and differentiation mutually exclusive? For ex-
ample, would the differentiation program be affected if the
zone of proliferation is expanded beyond the crypt onto the
villus or if the rate of migration is accelerated or retarded?
Third, is geographic differentiation along duodenal-to-co-
Ionic axis related to, or accompanied by, subtle differences
in proliferation/migration? Transgenic and chimeric mice
have been very useful for examining lineage relationships
among the gut's epithelial cell populations and for mapping
cis-acting elements that regulate the cellular and geographic
patterns of transcription of several genes in fetal, neonatal,
and aging animals (Ponder et al ., 1985; Sweetser et al .,
1988a,b; Hauftet al., 1989; Roth et al., 1990, 1991a,b; Roth
and Gordon, 1990; Rubin et al., 1991; Hansbrough et al .,
1991). However, a cell culture model that could mimic, at
leastto some degree, the processes of proliferation, commit-
ment, and gut epithelial cell differentiation would facilitate
an analysis of the first two questions.
HT-29 is a cell line derived from a human colonadenocar-
cinoma (Fogh and Trempe, 1975). These cells proliferate
rapidly when cultured in the presence of glucose. Upon
reaching confluence, most cells continue to divide and form
a multi-layer. Only a small proportion of cells have an
enterocyte-like phenotype (Pinto et al., 1982; Lesuffleur et
al., 1990) . Pinto et al. (1982) noted that if HT-29 cells were
cultured for several passages in the absence of glucose (e.g.,
using galactose as the carbon source), they would stop divid-
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ing upon reaching confluence, form a true monolayer, and
"differentiate=acquiring many of the features of enterocytes
including morphologic polarization, an apical brush border
with brush border specific hydrolases, and tight junctions.
Louvard and co-workers (Huet et al., 1987) reported that
confluent monolayers of differentiated HT29 cells exhibited
two phenotypes: 10% of cells resembled the mucus-secret-
ing goblet cell while -90% were enterocyte-like. Since all
of the cellswere derived from a single clone, they concluded
that HT-29 cells are multipotent. Together these results sug-
gest that (a) HT-29 cells which have been cultured in the
presence of glucose may resemble multipotent intestinal
stem cells; (b) proliferating HT-29 cells that have been cul-
tured in the absence of glucose may resemble pre-differen-
tiated crypt cell populations that are committed to differenti-
ate into either enterocytes or goblet cells; and (c) cells that
have been cultured in the absence of glucose and have been
maintainedin a confluent stateresemble terminally differen-
tiated enterocytes or goblet cells. These observations also
suggest that the HT-29 cell line couldbe exploited as a model
system for identifying potential molecular mechanisms which
regulate epithelial cell proliferation/commitment/differenti-
ation alongthe crypt-to-villus axis ofthe (human) gut. In this
report, we describe a strategy for surveying a cDNA library,
derived from proliferating HT-29 cells grown in the absence
of glucose, to identify potential mediators of these processes.
This surveyhas yielded a cDNA encoding a novel gut-specific
annexin.
Materials andMethods
Cellsand Culture Conditions
HT29 cells were obtained from Dr. Alain Zweibaum (INSERM U178,
Villejuif, France) and cultured in Dulbeccds modified minimal essential
medium (D-MEM) containing 10% dialyzed FBS, plus glucose (final con-
centration = 25 mM) or inosine (2.5 mM). Cells were grown in an at-
mosphere of 10% C02/90% air at 100% humidity. HT29/inol cells were
cultured in the presence ofinosine and absence of glucose for at least four
passages (15-20 cell doublings) before use ice et al., 1985). "HT-29 glc"
cells were always exposedto glucose as their exclusive carbon source. HT
29/ino and HT29/glc cells were initially plated at densities of 2 x 106 and
1 x 106 cells/25 cm2, respectively. "Log phase" cells were harvested 3-4 d
after plating while "postconfluent" cells were recovered 18-22 d after
plating.
CaCo-2, SW480, and HeLa (CCL2 and CCL2.2) cells were obtained
from the ATCC (Rockville, MD). CaCo-2 cells were cultured in D-MEM/
25 mM glucose/20% nondialyzedFBS/ix nonessential amino acids (Gibco
Laboratories, Grand Island, NY). SW480 cells were cultured in D-MEM
exactly as described for HT-29 cells. HeLa cells were grown in MEM-a
supplemented with 10% dialyzed FBS (clone CCL2.2) or glucose-free
MEM/Earle's salts (CCL2.2) containing 10% dialyzed FBS and 1 mM ino-
sine ice et al., 1981). "Log phase" and "postconfluent" CaCo-2, SW480,
and HeLa cells were defined in exactly the same way as described above
for HT-29 cells.
Procurement ofHuman 77ssues
Full thickness segments of gut, harvested along the duodenal-to-colonic
axis, were obtained from adult organ donors through the National Disease
Research Interchange (Philadelphia, PA). Additional tissue samples were
obtained as surgical specimens. Alltissues were snap-frozen in liquid nitro-
1.Abbreviationsusedin thispaper: HT29/ino, HT-29 cells grown in theab-
sence of glucose and the presence of2.5 mM inosine for at least four pas-
sages; HT29/glc, HT-29 cells grown exclusively in the presence of25 MM
glucose; ISA, intestine-specific annexin (Gut-2); NMT, myristoylCoA:
protein N-myristoyltransferase ; L-FABP liver fatty acid binding protein.
406gen and stored at -140°C. Tissues were procured using guidelines and pro-
tocols approved by our University's Human Studies Committee.
Isolation ofRNA
Total cellular RNA was extracted from cultured cells and from human tis-
sues using guanidinium thiocyanate and further purified by centrifugation
through cesium chloride gradients (Chirgwin et al., 1979). RNA integrity
was established after electrophoresis through methylmercury agarose or
formaldehyde agarose gels (Thomas, 1980) . PolyA+ RNA was prepared
from total cellular RNA by oligo-dT cellulose (Type 7, LKB-Pharmacia,
Uppsala, Sweden) chromatography. Samples oftotal cellular RNA isolated
from the entire small intestine of 12.5- and 15-wk human fetuses were
kindly provided by Dr. Nicholas O. Davidson (University of Chicago).
SynthesisandScreeningofacDNALibraryPrepared
from ProliferatingHT-29/ino Cells
A cDNA library of 6.7 x 106 independent recombinant phage was pro-
duced by directional cloning of double stranded cDNA into the Xbal/Eco
RI site of Lambda GEM-2 (Promega Biotec, Madison, WI). The strategy
for screening this library with subtracted cDNA probes was as follows.
PolyA+ RNA, prepared from HT29/ino cells harvested during log phase,
was reverse transcribed in the presence of [3ZP]dCTP with an Xbal-
oligodT primer-adaptor andavian myeloblastosis virus (AMV) reverse trans-
criptase (Davis et al., 1984). This cDNA contains sequences complemen-
tary to HT-29-specific mRNAs as well as to "housekeeping" mRNAs. An
unknown fraction ofthe former mRNAs should be intestine-specific. To re-
duce the number of cDNAs encoding "housekeeping" functions, the radio-
labeled probe (0.1 pg, specific activity = 1,300cpm/pg) was incubated with
1.2 ug of biotinylated polyA+ RNA (Sive and St. John, 1988) prepared
from proliferating HeLa cells cultured in the presence ofglucose. This epi-
thelial cell line was derived from a human cervical adenocarcinoma (Gey
et al., 1952; Jones et al., 1971) and should contain mRNAs that could hy-
bridize with"housekeeping", but notwith HT-29-specific, sequences present
in the HT29/ino/log cDNA preparation. Hybridization was allowed to pro-
ceed at 65°C for 40 h in a 5 Al reaction mixture containing N-[2-hydroxy-
ethyl]piperazine-N-[2-ethanesulfonic acid] (50mM, pH 7.6), SDS (0.2%),
EDTA (2 mM), and NaCl (0.5 M). Unhybridized, single-stranded, [3ZP]la-
beled cDNAs were separated from [32P]cDNA:biotinylated mRNA hy-
brids using avidin and the phase partitioning method described in Sive and
St. John (1988). A second round of subtraction, identical in all respects to
the first, was then performed. The final preparation of single stranded
[32p]labeled cDNA typically represented -10% of the starting material.
(N.B. control experiments using either radiolabeled biotinylated mRNA
alone, or labeled cDNA alone, indicated that the recovery of counts after
the phase partition protocol is >95%). This fraction, enriched for HT-29
"specific" sequences, was termed the "plus" probe.
Since the "plus" probe undoubtedly contained "housekeeping" sequences
that were not removed by the subtraction procedure, we also screened the
library with a "minus" probe designed to identify phage containing "house-
keeping" cDNAs. This "minus" probe was generated by synthesizing
[32p]labeled cDNA from polyA+ RNA prepared from log phase HeLa/glc
cells and hybridizing it (0.1 Ag, specific activity = 1,300 cpm/pg) with bi-
otinylated polyA+ RNA (1.2 kg) prepared from proliferating HT29/ino
cells. Hybridization conditions were identical to those described above. Af-
ter avidin/phase separation and a second cycle of subtraction, -10% ofthe
input counts were recovered as single-stranded cDNA. This fraction should
contain cDNAs that are specific to HeLa cells as well as housekeeping se-
quences which were not removed by the subtraction protocol. Because our
HT29/ino library cannot contain any HeLa specific cDNAs, any recom-
binant phage that hybridize with the "minus" probe should have cDNA in-
serts derived from "housekeeping" mRNAs.
100,000 recombinant phage from our proliferating HT29/ino cDNA li-
brary were screened as follows. Duplicate filters were prepared (Sambrook
et al., 1989) fromeach Petri dishcontaining25,000 plaques. All eight filters
were incubated in a solution containing forntamide (50%), NaCl (0.75 M),
sodium phosphate (50mM, pH 7.4), EDTA (5 mM), 1.5x Denhardt's solu-
tion (1 x Denhardt's = 0.02% Ficoll, 0.02 % polyvinylpyrrolidone, 0.02%
BSA), dextran sulfate (10%), SDS (0.1%) sheared, denatured salmon sperm
DNA (0.1 mg/ml), and the [32p]labeled "minus" probe (3 x 105 cpm/ml).
After a 40-h incubation at 42°C, filters were washed (final stringency =
0.lx SSC at 65°C) and subjected to autoradiography (typically filters were
exposed for 7 d to Kodak XAR film at -80°C using one intensifying
screen). As noted above, phage in the HT29/ino library that reacted with
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this "minus" probe should contain "housekeeping"cDNAs. Annealed probe
was removed from the filters by incubating them for 4 h at 65°C in the hy-
bridization solution described above (minus dextran sulfate). The filters
were then hybridized with the [3ZP]labeled plus probe (note that both plus
and minus probes had equivalent specific activities). Plaques that were plus
probe positive and minus probe positive were considered to have cDNAs
encoding "housekeeping" proteins. Their dual reactivity was presumed to
arise from the fact that the subtraction employed during preparation of the
"plus" probe failed to remove all housekeeping sequences. After sequential
screening with the "minus" followed by the "plus" probes, 15 plaques were
identified that reacted on duplicate filters with the "plus" probe but not the
"minus" probe. 11 plaques remained positive after secondary and tertiary
rounds of screening.
Phage DNA was prepared from each of the 11 purified plaques (Sam-
brook et al ., 1989). Their cDNA inserts were excised by digestion with
XbaI and EcoRl and purified by agarose gel electrophoresis and glass bead
catpwre (Geneclean, Bio 101, LaJolla, CA). Each insert was labeled with
[11P] using random hexanucleotide primers (Feinberg and Vogelstein,
1983, 1984), denatured, and subsequently used to probe Southern blots
containing all 11 purified Xbal/EcoRI fragments. The results ofthis survey
indicated that the 11 inserts were derived from four unique cDNAs (data
not shown).
DNA Sequencing
Xbal/EcoRl fragments were subcloned into pBluescript/KS (Stratagene,
LaJolla, CA). Nested deletions were generated from each end of the insert
using Exonuclease III, Mung Bean nuclease, and the protocol supplied in
Strategene's Exo/Mung kit. The sequenase II system (United States Bio-
chemical, Cleveland, OH) whichis based uponthe dideoxynucleotide chain
terminationmethod was employed for nucleotide sequencing: M13 "univer-
sal", "reverse" M13, T3, or T7 primers were utilized together with dena-
tured, double-stranded DNA templates. Oligodeoxynucleotide primers
were produced using phosphoramite chemistry and an Applied Biosystems
Model 380B Synthesizer to complete the sequencing of regions that were
not encompassed by the nested deletions. Both strands were completely se-
quenced.
Northern BlotAnalysis
Total cellular RNA(5-10 ug) containingbound ethidium bromide was frac-
tionatedby denaturing formaldehyde-agarosegel electrophoresis, and trans-
ferred to nitrocellulose filters (Thomas, 1980). Gels, as well as the nitrocel-
lulose filters containing bound RNA, were examined under short wave UV
light to verify that all lanes contained similar amounts of intact RNA and
that the efficiency oftransfer ofRNAwas similar for all samples. Blots were
probed with purified Xbal/EcoRl fragments labeled with [3ZP] using the
random primer method or with [3ZP]cRNAs prepared by in vitro run off
transcription of linearized recombinant pBluescript plasmids according to
protocols supplied by Promega Biotec (Madison, WI). Hybridization with
cRNA probes was conducted at 60°C in a solution containing fornramide
(50%), SSC (5x), sodium phosphate (50 mM, pH 7.4), SDS (0.1%), Den-
hardt's solution (2.5x), and sheared, denatured salmon sperm DNA (0.2
mg/ml). Blots were subsequently washed (final stringency = O.lx SSC at
70-75°C). Each blot contained internal standards of purified in vitro tran-
scribed mRNA (0.3-1000pg) to allow quantitation ofthe absolute levels of
a given mRNA species in preparations of total cellular RNA. Blots were
scanned using a Betagen Image Analyzer (Betagen, Waltham, MA).
In SituHybridizations
These analyses were performed on cryostat sections ofhuman jejunum and
colon based onthe method described in Ausubelet al. (1989). Pieces offro-
zen tissue were embedded in OCT and 10-Am sections were collected on
slides that had been coated twice with gelatin. Sections were fixed for 20
min at room temperature in a fresh solution of4 % paraformaldehyde (pre-
pared in PBS) and then dehydrated in graded alcohols. Samples were
acetylated with acetic anhydride and dehydrated once more. Hybridization
solution (fornramide [50%], dextran sulfate [10%], Denhardt's solution
[lx], EDTA [1 mM], Tris [10 mM, pH 8.0], NaCl [0.3 M], DTT [10 mM],
yeast tRNA [0.5 mg/ml], and [35S]labeled cRNA [5 x 106 cpm/ml, pre-
pared as described below]) was added to the tissue sections (80 Al/slide).
A coverslip was placed over the slide, its edges were sealed with DPX
Mountant (BDH Ltd., Poole, England), and hybridization was allowed to
proceedfor 12-16 h at 55°C. At the conclusion ofthis incubation, the cover-
407slip was removed, the section was washed four times in 4x SSC at room
temperature (5 min/wash), and thentreated for 30 min at 37°C with RNase
A (20 pg/ml ofbuffer containing NaCI (0.5 M), Tris (10 mM, pH 8.0), and
EDTA (1 mM)). After a 30-min wash in 0.lx SSC at 55°C, the sections
were dehydrated with graded alcohols, and the slides were dipped in Kodak
NTB2 emulsion. Slides wereexposed at4°C, then developed, fixed, stained
with hematoxylin, and counterstained with Eosin Y.
LabeledcRNA and mRNA probes for these in situ hybridization studies
were generated in the presence of[35S]UTP using linearized, recombinant,
pBluescript/KS DNA, and T3 or T7 RNApolymerase. The specific activity
of the purified in vitro transcribed RNAs was 2,000 cpm/pg. Their unique
specificities were established by Northern blot hybridization using cRNA
and mRNAs produced in an identical fashion except [32P]dCTP was sub-
stituted for [35S]UTP in the reaction mixture.
Generation ofAntipeptideAntibodies
An 18 amino acid peptide (GNRHAKASSPQGFDVDRC-NH2) was syn-
thesized using the Merrifield method with an Applied Biosystems Model
430 Synthesizer as described in Towler et a]. (1987) . This peptide spans
residues 2-18oftheprimary translationproductof Gut-2 cDNA (seebelow)
and contains an additional COOH-terminal cysteine. 4 mg of the purified
octadecapeptide was coupled to 2 mg of Keyhole Limpet hemocyocyanin
via this cysteine using 3-maleimidobenzyoyl-N-hydroxy-succinimidester
(Ausubel et al., 1989). After separation from unbound peptide, the con-
jugate was emulsified with Freund7s complete adjuvant (Sigma Chemical
Co., St. Louis, MO) and used to immunize two female New Zealand white
rabbits. A total initial dose of 300 pg conjugate was administered at five
intradermal sites. 4 wk later, and at 2-wk intervals thereafter, rabbits were
boosted with 150-30014g antigen in Freunds incomplete adjuvant. Each an-
imal produced antibodies that recognize the free peptide as determined by
ELISA.
Western BlotAnalyses
Cells or tissues were homogenized with a Tissue Mizer (Tekmar, Cincin-
nati, OH) in 2x Laemmli loading buffer (Laemmli, 1970) containing the
following protease inhibitors: E-64 (1 pg/ml), aprotinin (5 pg/ml), leupep-
tin (5 pg/ml), PMSF (0.5 mM), phosphoramidon (50 pg/ml), pepstatin (1
kg/ml), and EDTA (5 mM). After boiling, the proteins were separated by
electrophoresis through 10% polyacrylamide gels containing 0.1 % SDS and
then transferred onto nitrocellulose membranes. The resulting Western
blots were incubated with preimmune or immune rabbit sera in Blotto (5%
[wt/vol] non-fat dry milk, antifoam A [0.03%], Tween-20 [0.04%], sodium
azide [0.1%], NaCl [0.15 M], and Tris [10 mM, pH 7.5]) for 1-2 h at room
temperature. Blots were washed in Blotto (four washes of 10 min each at
room temperature) . Antigen-antibody complexes were detected by incubat-
ing the washed blots with [1251]Protein A (1 pCi/ml Blotto; specific activity
= 2-10 ACi/pg) for 30 min at room temperature followed by four washes
with Blotto (10 min/wash; each wash performed at room temperature).
Immunocytochemical Studies
Frozen samples of human jejunum or colon were embedded in OCT and
10-pin cryostat sections were prepared. Sections were fixed for 10 min in
100% methanol at 0°C, air dried, and stored at -20°C until use. Sections
were rehydrated in PBS and incubated for 30 min at room temperature in
blocking buffer (BSA [1%], powdered skim milk [0.2%], and Triton X-100
[0.3%] prepared in PBS). Primary antibodies were diluted in blocking
bufferand incubated with sections for 60minat roomtemperature. Sections
were subsequently washed with PBS (four washes of5 min each) and then
incubated for 60 min at room temperature with secondary antibodies (ob-
tained from Jackson ImmunoResearch Laboratories, West Grove, PA)
diluted 1:200 in blocking buffer containing 5 % normal goat sera. Sections
were washed with PBS and mounted in PBS/glycerol (1:1 vol/vol).
Immunocytochemical analyses of cultured cells were conducted in a
similar fashion exceptthat cells were cultured on glass coverslipsandrinsed
with PBS before being processed as described above.
The following primary antibodies were employed: mouse monoclonal
HSI4/34 (antihuman sucrase-isomaltase, antibody HSSI9inBeaulieu et al.,
1989, final dilution = 1:200); mouse monoclonalWE9 (antigoblet cell mu-
cin; Phillips et al., 1988; 1:10 dilution ofhybridoma medium); mouse mAb
HBB 3/755/42 which recognizes dipeptidyl-peptidase IV (Hauri et al.,
1985; 1:200); plus the rabbit polyclonal anti-GNRHAKASSPQGFDVDRC
sera (1:1,000).
The Journal of Cell Biology, Volume 116, 1992
In VitroMyristoylCoA:Protein
N-Myristoyltransferase Assay
Todetermine whether the primary translation productof Gut-2/ISA mRNA
(seebelow) is a substrate for myristoylCoA:protein N-myristoyltransferase
(NMT), an octapeptide representing its residues 2-9 (GNRHAKAS-NH2)
was synthesized and added to a coupled in vitro assay system developed by
Towler and Glaser (1986) and described in several of our earlier publica-
tions (Rudnick et al., 1990, 1991; Duronio et al., 1990b). Briefly, the assay
measures the transfer of myristate from myristoylCoA to the amino-
terminal Gly residue ofpeptide acceptors. It consists oftwo steps. The first
involves enzymatic generation of radiolabeled myristoylCoA using [3H]-
myristate and Pseudomonas acylCoA synthetase. The second step involves
addition ofpurified NMT (Rudnick et al., 1990) together with an octapep-
tide containing residues 2-9 of the candidate sequence. The enzymatically
generated acylpeptide is purified from the reaction mixture by reverse phase
HPLC and detected by an in-line scintillation counter (Kishore et al., 1991).
MetabolicLabelingStudies
Monolayers of proliferating HT29/ino cells were washed twice with PBS
and then incubated with glucose-free DMEM containing 2.5 mM inosine,
10% dialyzed and delipidated FBS (Chain and Knowles, 1976), and (a)
[9,10-3H]myristic acid or [9,10-3H]palmitic acid (39 Ci/mmole; 200
pCi/ml) (New England Nuclear, Boston, MA) or (b) L-[35S]methionine
(1,000 Ci/mmol; 100 ACi/ml). At the end ofthe 4-h labeling period, mono-
layers were washed twice in PBS. Cells were then lysed in PBS containing
sodiumdeoxycholate(1%), Triton X-100 (1%), SDS (0.1%), E-64 (1 Ag/ml),
EDTA (5 mM), leupeptin (5 pg/nil), aprotinin (5 pg/ml), PMSF (0.5 MM),
phosphoramidon (50 pg/ml), and pepstatin A (1 pg/ml). Cellular DNA was
shearedby passing the lysate through a 26-g syringe needle. Insoluble mate-
rial was removed by centrifugation for 2 min at 12,000 g. The resulting su-
pernatant was subsequently incubated for 12-16 h at 4°C with antipeptide
serum (1 Al serum/125 pg HT29/ino cell protein). Protein A-Sepharose
(Pharmacia, Uppsala, Sweden) was added and the incubation continued for
1-2 h at room temperature. The beads were then harvested by centrifuga-
tion, washed five times with the same lysis buffer described above except
the SDS concentration was 1% and NaCl was added to a final concentration
of 0.65 M. After a final wash with PBS, the bound antigens were eluted by
reduction and heat denaturation in 2 x Laemmli sample loading buffer and
then separated by electrophoresis through 10% polyacrylamide gel contain-
ing SDS (0.1%) (Laemmli, 1970). Gels were processed as described in
Heuckeroth and Gordon (1989) and Johnson et al. (1990) .
Results andDiscussion
HT-29CellsasaModelSystemforIdenti;fyingGene
Products thatAffect Intestinal Epithelial CellGrowth
andDifferentiation
Logarithmically growing HT29 cells, maintained in media
containing inosine as a carbon source, represent a useful
starting point for identifying sequences that may modulate
the balance between proliferation and differentiation of epi-
thelial cells along the crypt-to-villus axis of the human gut.
Selection of these cells for construction of a cDNA library
was based on the following observations and suppositions.
First, exponentially growing HT29/ino cells offerthe oppor-
tunity for obtaining gene products that may regulate prolifer-
ation of undifferentiated intestinal epithelial cells in the
crypt. Second, it appears that genes expressed during ex-
ponential growth in inosine are sufficientto "induce the ter-
minal differentiation program, i.e., if HT-29 cells are cul-
tured in the absence of glucose (e.g. in inosine) for several
passages without ever being allowed to reach confluence,
and glucose is then added when confluency is achieved, they
will still differentiate into both enterocyte-like and goblet
cell-like phenotypes (B. Wice and G. Trugnan, unpublished
observations) . In contrast, >95 % of cellsthat have been cul-
408Figure 1. Northern blot analysis ofRNA prepared from proliferat-
ing HT29/ino and HeLa/glc cells usingcDNAs recovered from the
library screening. P'P]labeled cDNA inserts from each of four
independent recombinant phage DNA were used to probe blots of
total cellular RNA (10 ug/lane) prepared from the indicated cell
lines . The positions of migration of 28S and 18S rRNA are indi-
cated . Note that Gut-1 cDNA reacts with two different abundant
mRNÀs, whereas Gut-2, Gut-3, and Gut-4 cDNA each hybridize
to a single dominant transcript . These latter cDNAs do react with
larger and less abundant transcripts present in the total cellular
RNA samples . They presumably represent partially processed nu-
cleartranscripts which are present in HT29/ino but not HeLa cells .
Note that the exposure time for this autoradiograph was 4 d allow-
ing us to emphasize the degree ofconfidence that underlies the con-
clusion that Gut-1, Gut-2, Gut-3, and Gut-4mRNAs are not present
HeLa cells.
tured in the presence of glucose during logarithmic growth
fail to acquire the ability to express a differentiation pro-
gram . Third, if the differentiated state represents the product
of continued active regulation rather than the result of a se-
ries of irreversible binary decisions (Blau and Baltimore,
1991), nonproliferating, postconfluent cells should express
genes that regulate differentiation . However, devising a
strategy for identifying thesecDNAs in a library constructed
from postconfluent HT29/ino cells appeared to us to be
more difficult than one constructed from proliferating, un-
differentiated (but committed) HT29/ino cells since we an-
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Figure 2 . Nucleotide sequence ofISA (Gut-2)cDNA and its deduced
primary translation product .
ticipated a large number of sequences in the former to be
markers, rather than regulators, of the differentiated state .
The protocol used for screening an exponentially growing,
HT29/ino cDNA library for intestine-specific sequences
thatmay regulate epithelial cell growth and/or differentiation
is discussed in Materials and Methods . Four unique cDNAs
were identified from the 100,000 recombinant phage sur-
veyed . These cDNAs were subsequently incubated with
Northern blots oftotal cellularRNA prepared from prolifer-
ating HT29/ino and proliferating HeLa/glc cells. As ex-
pected from the experimental design of the library screen,
each of the labeled cDNAs only hybridized to transcripts
present in HT-29 cells (Fig . 1) . To determine whether any or
all of thesecDNAs were relatively specific for the intestinal
epithelium, an additional set of Northern blots was con-
structed containing total cellular RNA from adult human
small intestine, stomach, liver, kidney, heart, and placenta .
All four cDNAs reacted with unique mRNAs present in
small intestine. Each of these four mRNAs appeared to be
identical in size to those detected in proliferating HT29/ino
cellular RNA (data not shown) . The mRNA tentatively
named Gut-2 was the only one whose accumulation was
limited to the small bowel : Gut-1 mRNA is also present in
liver, Gut-3 mRNA is present in liver and stomach, while
1 CGTTGCTGTCGGTAAACTTTGCCTGTAGGAGGACTGATCTCTTAATGAAATACAGAAAAA
61 CCATCTCAGAAAAAGGAAAATGGGCAATCGTCATGCTAAAGCGAGCAGTCCTCAGGGTTT
M G N R H A K A S S P Q G F 14
121 TGATGTGGATCGAGATGCCAAAAAGCTGAACAAAGCCTGCAAAGGAATGGGGACCAATGA
D V D R D A K K L N K A C K G M G T N E 34
181 AGCAGCCATCATTGAAATCTTATCGGGCAGGACATCAGATGAGAGGCAACAAATCAAGCA
A A I I E I L S G R T S D E R Q 0 I K Q 54
241 AAAGTACAAGGCAACGTACGGCAAGGAGCTGGAGGAAGTACTCAAGAGTGAGCTGAGTGG
K Y K A T Y G K E L E E V L K S E L S G 74
301 AAACTTCGAGAAGACAGCGTTGGCCCTTCTGGACCGTCCCAGCGAGTACGCCGCCCGGCA
N F E K T A L A L L D R P S E Y A A R 0 94
361 GCTGCAGAAGGCTATGAAGGGTCTGGGCACAGATGAGTCCGTCCTCATTGAGTTCCTGTG
L Q K A M K G L G T D E S V L I E F L C 114
421 CACGAGGACCAATAAGGAAATCATCGCCATTAAAGAGGCCTACCAAAGGCTATTTGATAG
T R T N K E I I A I K E A Y 0 R L F D R 134
481 GAGCCTCGAATCAGATGTCAAAGGTGATACAAGTGGAAACCTAAAAAAAATCCTGGTGTC
S L E S D V K G D T S G N L K K I L V S 154
541 TCTGCTGCAGGCTAATCGCAATGAAGGAGATGACGTGGACAAAGATCTAGCTGGTCAGGA
L L Q A N R N E G D D V D K D L A G Q D 174
601 TGCCAAAGATCTGTATGATGCAGGGGAAGGCCGCTGGGGCACTGATGAGCTTGCGTTCAA
A K D L Y D A G E G R V G T D E L A F N 194
661 TGAAGTCCTGGCCAAGAGGAGCTACAAGCAGTTACGAGCCACCTTTCAAGCCTATCAAAT
E V L A K R S Y K Q L R A T F 0 A Y 0 I 214
721 TCTCATTGGCAAAGACATAGAAGAAGCCATTGAAGAAGAAACATCAGGCGACTTGCAGAA
L I G K D I E E A I E E E T S G D L Q K 234
781 GGCCTATTTAACTCTCGTGAGATGTGCCCAGGATTGTGAGGACTATTTTGCTGAACGTCT
A Y L T L V R C A Q D C E D Y F A E R L 254
841 GTACAAGTCGATGAAGGGTGCGGGGACCGATGAGGAGACGTTGATTCGCATAGTCGTGAC
Y K S M K G A G T D E E T L I R I V V T 274
901 CAGGGCCGAGGTGGACCTTCAGGGGATCAAAGCAAAGTTCCAAGAGAAGTATCAGAAGTC
R A E V D L Q G I K A K F Q E K Y Q K S 294
961 TCTCTCTGACATGGTTCGCTCAGATACCTCCGGGGACTTCCGGAAACTGCTAGTAGCCCT
L S D M V R S D T S G D F R K L L V A L 314
1021 CTTGCACTGAGCCAAGCCAGGGCAATAGGAACACAGGGTGGAACCACCTTTGTCAAGAGC
L H
1081 ACATTCCAAATCAAACTTGCAAATGAGACTCCCGCACGAAAACCCTTAAGAGTCCCGGAT
1141 TACTTTCTTGGCAGCTTAAGTGGCGCAGCCAGGCCAAGCTGTGTAAGTTAAGGGCAGTAA
1201 CGTTAAGATGCGTGGGCAGGGCACCTTGAACTCTGGCTTAGCAAGCATCTAGGCTGCCTC
1261 TTCACTTTCTTTTAGCATGGTAACTGGATGTTTTCTAAACACTAATGAAATCAGCAGTTG
1321 ATGAAAAAACTATGCATTTGTAATGGCACATTTAGAAGGATATGCATCACACAAGTAAGG
1381 TACAGGAAAGACAAAATTAAACAATTTATTAATTTTCCTTCTGTGTGTTCAATTTGAAAG
1441 CCTCATTGTTAATTAAAGTTGTGGATTATGCCTCT(A)32B
Gut-4 accumulates in stomach, kidney, and placenta (data
not shown) . We selected Gut-2 for further characterization
given the fact that this limited survey suggested intestinal-
specificity.
Gut-2cDNA SpecifiesaProtein ThatIsa New
MemberoftheAnnexinfamily
The complete nucleotide sequence of Gut-2 cDNA is shown
in Fig. 2 . The size of the cDNA (1,507 bases) is in close
agreement with the estimated length of its mRNA (-1,500-
1,600 bases; Fig. 1) . A favorable consensus sequence for ini-
tiation of translation surrounds the first ATG at nucleotides
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Figure 3 Alignment of human annexins. (A) FASTP alignment
(Pearson and Lipman, 1988) of ISA with human annexins (AN) I
and II. The readeris referred to Pepinsky et al. (1988) for the results
of multiple sequence alignments between other members of the
annexin family; : and . indicate identical aminoacidsandconserva-
tive substitutions, respectively, are present at this position in ISA
and ANI or ANII. An asterisk indicates that the same amino acid
is present at comparable positions of ISA, ANI, and ANII. (B)
Alignment of the amino-terminal domains of the human annexins.
The dots represent gaps inserted between their divergent amino-
terminal domains and beginning of theirconserved first repeating
domain.
80-83 : an adenine is positioned three bases upstream from
the Met codon whilea guanosine is located four basesdown-
stream (Kozak, 1987) . A rare, but efficient polyadenylation
signal (ATTAAA; Wickens, 1990) spans nucleotides 1,452-
1,457. The deduced sequence of the primary -translation
product of Gut-2 mRNA contains 316 amino acids and has
a calculated mass of 35,463 D.
A search of protein and nucleic acid databases was con-
ducted. A survey of versions 27.0 and 67.0 ofthe EMBL and
GenBank DNA databases, respectively, with FASTA (Pear-
son and Lipman, 1988) yielded 43 annexin (lipocortin)
cDNA entries, representing eight unique human annexins,
ANI MAMVSEFLKQAWFIENEEQEYVQTVKSSKGGPG 33
ISA MGNRH 5
AN2 MSTVHEILCKLSLEGDHSTPPSAY 24
AN1 SAVSPYPTFNPSSDVAALHKAIMVKGVDEATIIDILTKRNNAQRQQIKAAYLQETGKPLDETLKKALTGHLEEVVLALLKT 114
ISA AKASSPQGFDVDRDAKKLNKACKGMGTNEAAIIEILSGRTSDERQQIKQKYKATYGKELEEVLKSELSGNFEKTALALLDR 86
AN2 GSVKAYTNFDAERDALNIETAIKTKGVDEVTIVNILTNRSNAQRQDIAFAYQRRTKKELASALKSALSGHLETVILGLLKT 105
AN1 PAQFDADELRAAMKGLGTDEDTLIEILASRTNKEIRDINRVYREELKRDLAKDITSDTSGDFRNALLSLAK 185
ISA PSEYAARQLQKAMKGLGTDESVLIEFLCTRTNKEIIAIKEAYQRLFDRSLESDVKGDTSGNLKKILVSLLQ 157
AN2 PAQYDASELKASMKGLGTDEDSLIEIICSRTNQELQEINRVYKEMYKTDLEKDIISDTSGDFRKLMVALAK 176
AN1 GDR-SEDFGVNEDLADSDARALYEAGERRKGTDVNVFNTILTTRSYPQLRRVFQKYTKYSKHDMNKVLDLELKGDIEKCLTAIV 268
ISA ANR-NEGDDVDKDLAGQDAKDLYDAGEGRWGTDELAFNEVLAKRSYKQLRATFQAYQILIGKDIEEAIEEETSGDLQKAYLTLV 240
AN2 GRRAEDGSVIDYELIDQDARDLYDAGVKRKGTDVPKWISIMTERSVPHLQKVFDRYKSYSPYDMLESIRKEVKGDLENAFLNLV 260
AN1 KCATSKPAFFAEKLHQAMKGVGTRHKALIRIMVSRSEIDMNDIKAFYQKMYGISLCQAILDETKGDYEKILVALCGGN 346
ISA RCAQDCEDYFAERLYKSMKGAGTDEETLIRIVVTRAEVDLQGIKAKFQEKYQKSLSDMVRSDTSGDFRKLLVALLH 316
AN2 QCIQNKPLYFADRLYDSMKGKGTRDKVLIRIMVSRSE'.TDLß..: .ISEFKRKYGKSLYYYIQQDTKGDYQKALLYLCGGDD 339
ISA MGNRH . . . . . . . . . . . . . . . . . . . . . . . . . . . . AKASSPQGFDVDRDAKKL
ANI MAMVSEFLKQAWIENEEQEYVQTVKSSKGGPG SAVSPYPTFNPSSDVAAL
AN2 MSTVHEILCKLSLEGDHSTPPSAY . . . . . . . . . GSVKAYTNFDAERDALNI
AN3 MASIVVGHR. . . . . . . . . . . . . . . . . . . . . . . . GTVRDYPDLFSPSVDAEAI
AN4 MAMATKG. . . . . . . . . . . . . . . . . . . . . . . . . . GTVKAASGFNAMEDAQTL
AN5 MAQVLR. . . . . . . . . . . . . . . . . . . . . . . . . . . GTVTDFPGFDERADAETL
AN6 MAKPAQGAKYR . . . . . . . . . . . . . . . . . . . . . . GSIHDFPGFDPNQDAEAL
AN7 MSYPGYBPTGY . .132aa . .SQPATVTQVTQ. . GTIRPAANFDAIRDAEIL
ANB MANNKSÜIEQEG . . . . . . . . . . . . . . . . . . . . . VTVKSSSHFNPDPDAETLthat are related to Gut-2 . Each of these cDNAs shares
50-60% identity with Gut-2 cDNA over a span of900-1,000
nucleotides . This level of identity is limited to their protein
coding regions.
FASTP alignments (Pearson and Lipman, 1988) revealed
that Gut-2 has44% identity with human annexin I over a 313
amino acid span and 44% identity with human annexin II
over a 302 residue region (Fig . 3 A) . Based on this degree
of identity, we concluded that Gut-2 represents a new mem-
ber ofthis protein family and named it intestine-specific an-
nexin (ISA) .
The annexins were originally described as steroid-induc-
ible proteins that inhibit phospholipase A 2 (PLA 2) activity
in vitro (Flower et al ., 1984) . The annexins/lipocortins were
originally named based on their proposed functions . Differ-
ent groups have assigned different names to the same pro-
tein, resulting in a complex and confusing nomenclature .
The reader is referred to Pepinsky et al . (1988), Geisow et
al . (1990), and Crumpton and Dedman (1990) for tables list-
ing the various names for annexins/lipocortins . We have used
the term annexin as suggested by Crompton and Dedman
(1990) . Pepinsky and co-workers were able to purify a num-
ber of annexins based upon their calcium-dependent inhibi-
tion ofPLA2 and isolate the corresponding cDNAs (Huang
et al ., 1986 ; Wallner et al ., 1986 ; Pepinsky et al ., 1986,
1988) . While the precise physiological functions of these
proteins have notbeen established, a number ofobservations
suggest that they may play important roles in the regulation
of cellular growth and in signal transduction pathways . For
example, annexin I (p35) is the major physiological substrate
for the EGF receptor/tyrosine kinase in vivo (Sawyer and
Cohen, 1985 ; De et al ., 1986) . Annexin II (p36 ; Saris et al .,
1986 ; Huang et al ., 1986), is the dominant phosphorylated
protein in Rous sarcoma virus transformed fibroblasts, lead-
ing to the suggestion that it is a substrate for the p60°-5«
tyrosine kinase (Erikson and Erikson, 1980) . Monomeric
annexin II and phosphoglycerate kinase have also been im-
plicated (Jindal and Vishwanotha, 1990 ; Jindal et al ., 1991)
as the two cofactors in the "primer recognition protein com-
plex" that interacts with DNA polymerase a, the enzyme
responsible for synthesizing the lagging strand of DNA dur-
ing DNA replication . Annexin III is identical to inositol 1:2
cyclic phosphate 2-phosphohydrolase (Ross et al ., 1990) and
probably controls the intracellular levels ofall inositol cyclic
phosphates. These cyclic phosphates are thought to be im-
portant for the sustained, or delayed, action of effectors in
signal transduction pathways since they remain in stimulated
cells longer than the noncyclic forms . Overexpression of an-
nexin III in 3T3 cells results in a reduction in their density
at confluency (Ross et al., 1991) . Annexin VII can act as a
voltage-dependent calcium channel (see Pollard and Rojas,
1988 ; Burns et al ., 1989) . In addition toproposed regulatory
roles in growth and signal transduction, a large number of
annexins have also been implicated in exocytosis (Zaks and
Creutz, 1990a,b ; Creutz et al ., 1987; Ali et al ., 1989 ; Drust
and Creutz, 1988 ; Creutz, 1981 ; Hong et al ., 1981 ; Creutz
et al ., 1978) .
Previous alignments of annexins have revealed a consid-
erable degree of overall sequence similarity (-50% ; see
Pepinsky et al., 1988) . Moreover, each of the annexins has
been highly conserved over the course ofmammalian evolu-
tion : the human and rat homologues of annexins I, III, and
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Figure 4 . Expression ofISA mRNA in a variety ofcell lines derived
from human colonic adenocarcinomas as a function of their growth
and differentiation . Northern blots were prepared from formalde-
hyde agarose gels containing 10 ug of each sample oftotal cellular
RNA and probed with a full-length [ 32p]labeled Gut-2 cDNA .
Exposure time for the autoradiograph of the washed blot = 4 d .
Carbon source : I, inosine ; G, glucose . Growth phase : L, logarith-
mically growing cells ; C, cells maintained in a confluent state for
10-14 d . Differentiation was based on the presence of immunoreac-
tive sucrase-isomaltase, aminopeptidase N, and/or dipeptidylpep-
tidase IV .
V share 89, 85, and 89% identity, respectively (Pepinsky et
al ., 1988), while human and mouse annexin II are -98%
identical (Saris et al., 1986) . A domain of-70 amino acids
is repeated four times in the 35-40-kD annexins and eight
times in the 68-kD annexins . These domains are believed to
be important for calcium and phospholipid binding (reviewed
in Crompton et al ., 1988) . Calcium, in turn, is required for
the association of annexins with membranes and/or cyto-
skeletal proteins . Unlike their highly conserved repetitive
domains, the amino-terminal regions of each annexin have
diverged considerably, raising the possibility that this do-
main of 5-154 residues is important for the unique function
of each annexin . For example, the unique tyrosine phos-
phorylation sites for annexins I and II are located in this
domain . ISA lacks a comparably positioned amino-terminal
Tyr. (While phosphorylation can affect the calcium and phos-
pholipid binding properties of some annexins [Schlaepfer
and Haigler, 1987; Powell and Glenney, 1987], the precise
physiologic relevance of their phosphorylation is generally
unclear.)
Expression ofISA in Human Intestinal
Epithelial-Derived Cell Lines
Annexin I may play a role in the differentiation programs ofFigure 5. Surveys of ISA mRNA levels in adult human tissue RNÀs and in cellular components of the immune system . Northern blots
containing 5 ug of total cellular RNA (A and B and the HT29/ino sample in C) or 10 pg of total cellular RNA (all the other samples
in C) were probed with a full-length [32P]labeled ISAcRNA probe as described in Materials and Methods . The exposure time of the au-
toradiographs = 6 d except for the left hand lane of panel A containing log phase HT29/ino RNA which shows the same gel but exposed
for only 3 h . PBMNC peripheral blood mononuclear cells ; PBmm, peripheral blood macrophages ; SpMNC, splenic mononuclear cells ;
+ stimulated, cells treated with mitogen for 24 h before they were harvested. The faint band observed in all samples is due to hybridization
of the labeled ISA cRNA probe with 28S rRNA despite the high stringency wash conditions employed .
some cultured cell lines (William et al ., 1988 ; Violette et al .,
1990) . Therefore, we next defined the pattern of ISA expres-
sion in various human gut-derived cell lines to determine if
it is regulated as a function oftheir growth and/or differentia-
tion . Fig. 4 shows that ISA mRNA is readily detected in
proliferating HT29/ino cells (i .e ., cells committed to differ-
entiate) . Postconfluent HT29/ino cells that are expressing
their differentiation program exhibit a modest (less than two-
fold) reduction in the concentration of ISA mRNA relative
to that observed in exponentially growing cells . HT29/glc
cells do not contain detectable levels of this mRNA regard-
less of the growth phase sampled (Fig . 4) . Since very few
(<5 %) HT29/glc cells differentiate when they become con-
fluent (Pinto et al ., 1982 ; Lesuffieur et al ., 1990), it appears
that accumulation of ISA mRNA is restricted to committed
or differentiated HT-29 cells .
CaCo-2 (Fogh et al ., 1977) and SW480 (Leibowitz et al .,
1976) are two other cell lines derived from human colon
adenocarcinomas . CaCo-2 cells will differentiate spontane-
ously in culture after they become confluent, even in the
presence of glucose (Pinto et al ., 1983) . Unlike HT-29 cells,
they will only express an enterocyte-like phenotype . SW480
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cells do not differentiate in culture regardless of the growth
conditions employed (Chantret et al ., 1988) . ISA mRNA
was not detectable in proliferating or postconfluent CaCo-2
cells (Fig . 4) . In addition, it was not detectable in proliferat-
ing HeLa cells or in growing or postconfluent SW480 cells
whether cultured in glucose or inosine containing media
(Fig . 4 and data not shown) . These observations allow us to
conclude that accumulation of ISA mRNA is not simply a
cellular response to being cultured in the absence ofglucose .
The data are compatible with the notion that ISA could play
a role in regulating the growth and/ordifferentiation of some,
but not all, intestinal epithelial cell lines .
The Northern blot shown in Fig . 4 was subsequently re-
probed with an oligonucleotide (5'-CCA000CTGCTTGAG-
GAATTCTGATACCATTGCCAT3) complementary to the
region ofhuman annexin ImRNA encoding residues 1-18 of
its primary translation product (Wallner et al ., 1986) . An-
nexin I mRNA was detected in HT-29, CaCo-2, and SW480
cells, although its steady-state levels varied several fold as a
function of cell type, growth phase, and culture conditions
(data not shown) . Annexin I mRNA was also detected in
HeLa/glc and in ahuman hepatocyte-like cell line (HepG2) .
412Thus, annexin I gene expression is not restricted to intestinal
epithelial cell lines nor can its expression be correlated with
their ability to differentiate. The presence of annexin I mRNA
in a wide variety of cell lines and tissues (Pepinsky et al.,
1986; Huang et al ., 1986) is typical for annexins (Gould et
al., 1984; Greenberg et al ., 1984; Shadle et al., 1985 ; De
et al ., 1986; Pepinsky et al., 1986; Kaetzel et al ., 1989). ISA
appears to represent an exception to this "rule7 .
ISA mRNA IsNotDetectable in a Variety of
extra-intestinalAdultHuman Tissues
Although our initial survey of six humantissue RNAs (stom-
ach, small intestine, kidney, liver, heart, placenta) indicated
that ISA mRNA was limited to the intestine (Fig. 5), we ex-
tended these studies to other cellular populations to further
assess its distribution in adult humans. Quantitative RNA
blot hybridization analysis indicated that the steady-state
level of ISA mRNA in exponentially growing HT29/ino
cells is -15 pgliLg total cellular RNA. RNA prepared from
skeletal muscle, lung, fibroblasts, peripheral blood macro-
phages, peripheral blood, or splenic mononuclear cells also
failed to react with ISA cDNA (Fig. 5, A-C) . These
mononuclear cells express high levels of annexin I (Fava et
al., 1989 and data not shown), but do not contain detectable
ISA mRNA even if RNA is prepared 24 h after mitogenic
stimulation with phytohemagglutinin plus phorbolmyristic
acid (mononuclear cells) or with S. aureus Cowan I (macro-
phages) (Fig. 5 C) .
Expression ofISA Appears toBe
TemporallyandSpatially Regulatedin the
Human IntestinalEpithelium
To further define ISA gene expression in the human intestine,
we analyzed a series of samples of duodenum, jejunum, il-
eum, and colon from each of three organ donors aged 32,
36, and 72 yr. Total cellular RNA was isolated from two sep-
arate portions of each full thickness intestinal segment from
each donor. Fig. 6 shows that the steady-state levels of ISA
mRNA varies dramatically along the duodenal-to-colonic
axis. Highest levels are encountered in the jejunum (N4 pg/
lAg total cellular RNA, see Fig. 5) . Levels in the duodenum
and ileum are two- to fourfold lowerwhile those in the distal
colon are -90 fold lower. Remarkably, there was little varia-
tion in the absolute levels of ISA mRNA within each com-
parable segment harvested from each of the three organ
donors (Fig. 6, A and B) .
The liver fatty acid binding protein (L-FABP) gene is ex-
pressed in hepatocytes and enterocytes. It has been used as
a model for mapping cis-acting elements that regulate cellu-
lar and geographicdifferentiation of the gut epithelium in the
mouse (Sweetser et al., 1988a ; Roth et al., 1990, 1991b;
Roth and Gordon, 1990; Cohn et al., 1991; Rubin et al.,
1991). Control experiments employing a human L-FABP
cDNA (Lowe et al ., 1985) revealed that the distribution of
its mRNA along the duodenal-to-colonic axis was distinct
from that of ISA mRNA, varying less than twofold between
segments (Fig. 6, A and B). This pattern of accumulation of
L-FABP mRNA is similar to the results ofprevious immuno-
cytochemical surveys of its protein product in different
regions of the human intestinal tract (Suzuki et al., 1988) .
We were able to examine two samples ofhuman fetal total
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Figure 6. Distribution of ISA and L-FABP mRNAs along the duo-
denal to colonic axis of the adulthuman intestine. A representsthe
results ofsurveying two RNA samples prepared from each segment
of two organ donors' intestines. Note that samples from the entire
length ofintestine from each ofthesedonors was screened by quan-
titative RNA blot hybridization analysis as described in Materials
and Methods. B shows the results of an analysis of a third organ
donor whose duodenal-to-colonic axis was more extensively dis-
sected. Single total cellular RNA samples were prepared from each
ofthe indicated segments. D, duodenum; PJ, proximal jejunum; J,
midjejunum; DJ, distal jejunum; I, ileum; PC, proximal colon; C,
mid colon; and DC, distal colon.
small intestine RNA. The levelofISA mRNA in 12 .5-wk fe-
tal gut was -10-fold higher than in adult jejunum while its
concentration in a sample of 15-wk intestine was similar to
that in the adult (data not shown). It is intriguing to note that
the relatively "elevated" level of ISA mRNA in 12.5-wk fetal
gut occurs just at the completion of cytodifferentiation of its
epithelium (this period spans the eighth through twelfth
weeks of gestation ; Dahlqvist and Lindberg, 1966; Moxey
and Trier, 1978, 1979; Auricchio et al., 1981) . While these
observations are compatible with the notion that ISA is in-
volved in intestinal epithelialcell growth and differentiation,
it is important to exercise caution in interpreting the data
since the range in ISA mRNA levels between individuals at
each developmental stage could not be assessed. However,
note that the steady-state levels of ISA mRNA in comparable
regions of gut harvested from several adult individuals are
quite similar (Fig. 6).
A series ofin situ hybridization experiments was performed
to determine if the ISA gene is transcribed in gut epithelial
cells and, if so, whether its mRNA demonstrates variations
in steady-state levels as cells differentiate during their trans-
location along the crypt-to-villus axis. A [35S]-labeled cRNA
probe complementary to nucleotides 1-156 of ISA mRNAThe Joumal of Cell Biology, Volume 116, 1992
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414(Fig. 2) was used for these studies because of its lack of
sequence identity with other human annexin mRNAs. Con-
trol Northern blot hybridizations employing this cRNA (la-
beled with 32P) gave results that were identical to those
shown in Figs. 4 and 5.
In the adultjejunum, epithelial cells located at the crypt/
villus junction possess the highest levels ofISA mRNA with
much lower intracellular concentrations noted in epithelial
cells situated in the lower and mid thirds of the crypt (Fig.
7, A-D). Only modest variations in ISA mRNA levels were
noted as cellsmigrate from the base ofthe villus to the apical
extrusionzone. ISA mRNAwas not detectable in the nonepi-
thelial cellular populations of the lamina propria, in smooth
muscle myocytes, or in components of the enteric nervous
system (Fig. 7, A-D) . No signal was observed in control
jejunal sections incubated with anin vitrotranscribed, radio-
labeled mRNA probe derived from nucleotides 1-156 of ISA
cDNA (Fig. 7 E). The pattern of ISA mRNA accumulation
differs from that of L-FABP mRNA which is present in
villus-associated enterocytes but not in proliferating, undif-
ferentiated crypt cellular populations (Fig. 7, XI).
The colon lacks villi. Studies in chimeric mice indicate
that differentiating colonic epithelial cells migrate up from
the crypt to a surface cuff of epithelium that surrounds the
crypt orifice (Schmidt et al., 1985a,b) . This hexagonal
shaped cuff represents the colonic homologue of the small
intestinalvillus. Surveys of sections obtained from adult hu-
man colon indicated that ISA mRNA is present at very low
levels in epithelial cells situated in the lowerportions of the
crypt. It is not detectable in the differentiated colonocytes lo-
cated in the surface cuff (data not shown) . These data are
consistent with the results ofour Northern blot studies (Fig.
6) . They contrast with colonic expressionof L-FABP mRNA
which first becomes detectable in mid-crypt-associated epi-
thelial cellsand is expressed at high levels as cellsdifferenti-
ate during their migration to the surface epithelialcuff (data
not shown) .
ImmunologicStudiesofISA Accumulation/Targeting
in Cultured HumanIntestinalCellLines
Polyclonal rabbit antibodies were raised against residues
2-18 ofISA to further examine this protein's cellular origins
and intracellular destination. Its amino-terminal domain was
selected for generation of antibodies because of the lack of
sequence similarity with other annexins (see Fig. 3 B and be-
low). Western blot studies using antipeptide sera prepared
from two different rabbits revealed two immunoreactive
polypeptides with calculated masses of 36 and 42 kD in
denatured, reduced protein extracts ofproliferating/undiffer-
entiated and postconfluent/differentiated HT29/ino cells
(Fig. 8 A). Similar-size proteins were detected in Western
blots ofjejunal, duodenal and colonic homogenates (Fig. 8
B). Both antisera revealed that the relative steady-state con-
centrations ofthe two immunoreactive polypeptides in these
intestinalsegments roughly parallel the steady-state levels of
ISA mRNA (compare Fig. 8 B with Fig. 6, A and B). As in
the case ofISA mRNA, the polypeptides were not detectable
(with either antisera) in homogenates prepared from grow-
ing or confluent HeLa/glc cells, human placenta, spleen,
liver, or lung (Fig. 8, A and B) . Moreover, these bands were
not observed when duplicate blots were probed with preim-
mune serum (data not shown) or when the immune sera were
preadsorbed with peptide (e.g., Fig. 8 C). It is important to
note that lung, liver, spleen, and placenta contain abundant
quantitiesofvarious annexins (Gould et al ., 1984; Greenberg
et al., 1984; Shadle et al., 1985; De et al., 1986; Pepinsky
et al., 1988; Kaetzel et al., 1989) . Together these results sug-
gest that our antisera recognize ISA and are specific for this
annexin. The calculated size of the smaller of the two reac-
tive species was identical to that predicted for the primary
translation product of ISA mRNA. The structural relation-
ship between this species and the larger immunoreactive
polypeptide remains to be determined, although they share
a common amino terminal modification (see below).
The anti-ISA sera was subsequently incubated with
methanol-fixed cultured cells. Fig. 9 (A and B) shows ISA
ispresentin most proliferating HT29/ino cells. Staining was
not observed with preimmune serum or if the antiserum was
preincubated with the octadecapeptide (data not shown). A
striking finding was the high concentration of immunoreac-
tive protein at or near the plasma membrane.
Growing or confluent HeLa/glc cells, which contain no
Figure 7 . In situ hybridization studies ofISA and L-FABP mRNA accumulation along the crypt-to-villus axis of the adulthuman jejunum.
Two [358]labeled cRNA probes were used for these studies: (a) a 156 nucleotide ISA fragment (spanning nucleotides 1-156 in Fig. 2) ob-
tained by runoff transcription of a recombinant, EcoRI digested pBluescript/KS plasmid with T7 RNA polymerase; (b) a 418 nucleotide
human L-FABP fragment obtained afterBamHI digestion of pBluescript/KS containing a 418-bp PstI DNA derived from pHF658 (Lowe
et al., 1985) and in vitro runoff transcription with T3 RNA polymerase. (A) A section of human jejunum that had been incubated with
the ISA cRNA probe, stained with hematoxylin and eosin, and viewed under bright field illumination (100x) ; (B) the same section as
shown in A but viewed under darkfield to "enhance" the signal from exposed silver grains. The arrows in A and B point to the base of
a crypt. Exposure time = 14 d; (C) higher powerview of B illustrating low level accumulation of ISA mRNA in crypt associated epithelial
cells (arrow). The lamina propria (LP) contains no detectable signal over background (200x); (D) higher power bright field view ofA
showing villus-associated epithelialcells containing ISA mRNA (1,000x). Again, cellular populations in the lamina propria do not appear
to express this annexin; (E) section taken from the same jejunal segment but probed with a control VSS]labeled ISA mRNA (rather than
cRNA) probe ofidentical specific activity and length. No signal above background is seen in this darkfield view (exposure time = 14 d,
100x); (F) darkfield view of a section of human jejunum after incubation with a human L-FABP cRNA probe. Note that accumulation
of this mRNA is confined to villus-associated enterocytes. Exposure time = 6 d (100x); (G) higher power view of section shown in F
demonstrating thatthe L-FABP is transcriptionally activated as cells traverse the crypt-villusjunction (indicatedby the open arrows, 200x);
(H) bright field view of G. The closed arrow in this panel and in G point to the base of the crypt; (I) higher power view of jejunal
villus-associated epithelium shown in H (1,000x). Note the absence of signal in the lamina propria (LP). Control experiments using a
P5S]labeled L-FABP mRNA probe of equal specific activity failed to produce any signal above background in adjacent jejunal sections
(data not shown).
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415Figure 8. Western blot surveys of HT-9, HeLa, and adult human
tissue homogenates for the presence of ISA . (A) Analysis of total
cell lysates (10,ug protein/lane) . Samples were reduced, denatured,
fractionated by electrophoresis through 10% polyacrylamide gels
containing SDS (0.1%), and transferred to nitrocellulose before
being probed with a rabbit polyclonal antisera directed against
residues 2-18 of the primary translation product of ISA mRNA .
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detectable levels of ISA mRNA (Figs . 4 and 5) or protein
(Fig . 8) are not stained with the antisera . Less than 2% of
HT29/glc cells were ISA-positive. The few cells that were
positive exhibited a pattern ofperipheral membrane staining
similar to HT29/ino cells (data not shown) . This is consis-
tent with the observation that very few HT29/glc cells
differentiate in vitro and with the results obtained from
Northern (Fig . 4) and Western (Fig . 8 A) blot studies.
Immunocytochemical Studies ofISA Expression in
AdultHuman Jejunum and Colon
Fig. 10A demonstrates that the apical brush border ofpolar-
ized, villus-associated, jejunal enterocytes is intensely stained
by the antipeptide serum . The basolateral membrane is less
prominently stained . Faint cytoplasmic staining can also be
appreciated . Epithelial cells located in the crypt also contain
ISA (Fig. 10 B), consistent with the distribution of itsmRNA
along the crypt-to-villus axis (Fig . 7) . Even in these undiffer-
entiated cells, ISA appears to be sorted to the plasma mem-
brane with higher concentrations present at the apical sur-
face . No staining was noted in cellular populations that
reside in the lamina propria . Control experiments using pre-
immune sera (Fig . 10 C) or peptide-adsorbed immune sera
(Fig . 10 D) establish the specificity of the reaction observed
between our antibodies and ISA .
The pattern of ISA expression in thejejunum differs from
that observed for sucrase-isomaltase (Fig . 10 F) or amino-
peptidase N (data not shown) . In differentiated enterocytes,
these brush border hydrolases are confined to the apical
membrane ; no basolateral staining can be appreciated . Re-
duced levels of immunoreactive protein are detectable at the
apical region of mid and upper crypt epithelial cell popula-
tions . The pattern of ISA accumulation also differs from (a)
the distribution ofmucus in differentiatedjejunal goblet cells
(Fig . 10 E) and (b) the intracellular distribution of annexin
II and IV in enterocytes (annexin II is restricted to the termi-
nal web region of the cell's apical border while annexin IV
is only associated with the basolateral membrane [Gould et
al ., 1984 ; Greenberg et al ., 1984 ; Massey et al ., 1991]) .
ISA is associated with the plasma membrane of epithelial
The antibody was diluted 1:10,000. Antigen-antibody complexes
were visualized with [125I]protein A . The washed blot was sub-
jected to autoradiography for 3 d . Note that faint 36- and 42-kD
bands were observed in HT29/Glc cell lysates . Proliferating HT
29/ino cells contain slightly higher steady state levels ofISA mRNA
than postconfluent cells (Fig . 4) . The data shown in this panel indi-
catethatthe levels of ISA are comparable in thetwo cellular popula-
tions, raising the possibility that either translational control mecha-
nisms contribute to the regulation of ISA expression or that the
stability of this protein changes after HT29/ino cells become con-
fluent . (B) Western blot of proteins contained in human tissue
homogenates. Each lane contains 20 ug of protein . The blot was
probed with the same antisera as used inA but now diluted 1:2,000.
Exposure time ofthe autoradiograph = 16 h . No immunoreactive
protein was detected in placenta, spleen, liver, and lung even after
a 3-d exposure . (C) Duplicate ofthe blot shown in B but incubated
with antisera that had been preadsorbed with the octadecapeptide.
The dilution of the sera was identical to that employed in B . Ex-
posure time = 16 h . N. B. no signal was seen after a 3-d exposure
(data not shown) .
416Figure 9 . Immunocytochemi-
cal studies of HT29/ino and
HeLa/glc cells using an anti-
peptide antibody against the
amino-terminal domain of
ISA . HT29/ino (A and B) or
HeLa/glc (C and D) were
plated on glass coverslips . 3 d
later, cells were washed with
PBS, fixedinMcOH, and incu-
bated withthe rabbit polyclon-
al antioctadecapeptide serum
followed by FITC-conjugated
goat antirabbit sera . (A) Phase-
contrast view of HT29/ino
cells ; (B) fluorescence micros-
copy of the same field as that
shown in A . Note the intense
staining seen at the periphery
of these cells (500x) . (C)
HeLa/glc cells seen under
phase ; (D) fluorescence micros-
copyofthe samecells as shown
in C (500x) .
cells located in colonic crypts (Fig . 10 G) . In contrast to
jejunal villus-associated enterocytes, ISA is not expressed in
terminally differentiated colonocytes (Fig . 10 G) . As in the
small bowel, the lamina propria does not contain im-
munoreactive ISA .
ISA Isa N-Myristoylprotein
ISA contains a Gly at position 2 . None of the other known
annexins begins with Met-Gly (Fig . 3 B) . Inspection of
residues 2-9 of ISA suggested that it may be a substrate for
myristoylCoA:protein N-myristoyltransferase (NMT; see
Towler et al ., 1988b for a summary of the peptide substrate
specificity of this acyltransferase) . This enzyme catalyzes
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the cotranslational attachment of myristate, a rare 14 carbon
saturated fatty acid, to the amino-terminal Gly residues of
a number of cellular and viral proteins (reviewed in Towler
et al., 1988b ; James and Olson, 1990; Gordon et al ., 1991) .
These proteins have diverse functions and diverse intracellu-
lar destinations. They include serine/threonine and tyrosine
kinases, protein phosphatases, as well as components of
transmembrane signal transducing pathways, e.g., a sub-
units of heterotrimeric G proteins (Mumby et al ., 1990 ;
Linder et al ., 1991) . N-myristoylation can have a profound
effect on targeting : Gly2-Ala mutagenesis of p60°-
blocks N-myristoylation, prevents its stable association with
a plasma membrane-associated 32-kD receptor (Resh,
1989 ; Resh and Ling 1990), and blocks its ability to trans-
form cells even though tyrosine kinase activity is not affected
(Cross et al ., 1984 ; Kamps et al ., 1985 ; Buss et al ., 1986) .
If the protein encoded by ISA mRNA were subjected to this
form of acylation, it would be unique among annexins. An-
nexins I, II, and V are substrates for another amino-terminal
processing enzyme-N-acetyltransferase (Biemann and Sco-
ble, 1987 ; Glenney et al ., 1986 ; Funakoski et al ., 1987; also
see Weber et al ., 1987 for evidence that other annexins may
have acetylated amino termini) .
We used an in vitro NMT assay containing a myristoyl-
CoA generating system, purified S. cerevisiae NMT, and an
octapeptide representing residues 2-9 of ISA to determine
whether this protein was likely to be a substrate for the
acyltransferase . This in vitro system has been used to estab-
lish that themammalian and yeast enzymes share a remark-
able degree of similarity in their acylCoA and peptide sub-
strate specificities (Towler et al ., 1988a) . The yeastNMT was
used for these studies because large quantities ofpure enzyme
have been obtained from E . coli strains containing suitably
constructed expression vector (Duronio et al ., 1990a,b,
1991 ; Rudnick et al ., 1990) . As shown in Table I, the octa-
peptide GNRHAKAS-NHZ has kinetic properties that are
comparable to those of octapeptides representing residues
2-9 of other known mammalian N-myristoylproteins .
Metabolic labeling studies provided additional evidence
that ISA is N-myristoylated . Incubation of HT29/ino cells
with [3IS]methionine and subsequent immunoprecipitation
of cellular lysates with antipeptide sera resulted in recovery
of two principal ['SS]polypeptides. The relative intensities
of the labeled 36- and 42-kD bands (Fig . 11, lane S) were
similar to the intensities of the 36- and 42-kD polypeptides
noted in the Western blot shown in Fig . 8. The immunopre-
cipitated proteins are not abundant-examination of total
cellular, [ 35S]methionine-labeled proteins separated by sin-
gle dimension SDS-PAGE failed to reveal prominent 36- or
42-kD species at the conclusion of the 4-h labeling period
(Fig . 11, compare lanes 1-3 with lane S) . The proteins were
not detectable in HT29/glc or HeLa cell lysates (Fig . 11,
lanes 4 and 6) .
When HT29/ino cells were incubated with [3H]myristate
for 4 h, 36- and 42-kD labeled polypeptides could also be
recovered by the antipeptide sera (Fig . 11, lane 8) . Proteins
of comparable size were not detected by the antibodies in
HeLa/glc or HT29/glc cell lysates prepared after a 4-h label-
ing with [ 3H]myristate (Fig . 11, lanes 7 and 9) . In addition,
a 4-h incubation of HT29/ino cells with [ 3H]palmitate
failed to produce labeling of immunoreactive 36- or 42-kD
41 7Figure 10 . Immunocytoehemical localization of ISA in human
jejunal and colonic epithelial cells . (A) Section ofadultjejunum in-
cubated with the rabbit polyclonal antipeptide sera . Immunoreac-
tive ISAwas visualized usingFTIC-conjugated goat antirabbit sera .
Theopen arrows point to the crypt villus junction while the closed
arrowhead indicates the base of the crypt . The luminal surface of
villus enterocytes stains intensely forISA . Fainter staining ofcrypt
epithelial cell membranes can be appreciated (200x) . (B) Higher
powerview ofAshowingISA associated with the apical membrane
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Table L In VitroNMTAssay Using
Oetapeptides Derivedfrom Residues 2-9 ofISA and
Several Known N-myristoylproteins
" Vm data have been expressed as a percentage of that observed with the PK-A
octapeptide (6 .5 x 10' pmol/min/mg NMT.
t Taken from Towler et al . (19886) .
Conditions employed for the coupled in vitro NMT assay are described else-
where (Rudnick et al ., 1990) . Peptide K. was determined in the presence of
0.23pM myristoylCoA usingS . cerevisiaeNMT . Experimentswereperformed
three times, each time in duplicate. Averaged values are shown .
proteins (Fig . 11, lane 11) even though the specific activity
of this radiolabeled C16:0 fatty acid was identical to that of
[3H]myristate .
To verify that the [3H]myristate had been covalently at-
tached to ISA via an amide linkage, SDS-polyacrylamide
gels containing labeled cellular proteins were treated with
1 M hydroxylamine (pH 10)or 1 M Tris, pH 10, before fluo-
rography. Hydroxylamine, but not Tris, will hydrolyze thio-
esterandoxyester bondsbutnotamidelinkages . Theintensi-
ties ofthe tritiated 36- and42-kDpolypeptides were identical
in gels treated with hydroxylamine (Fig . 11, lane 8) or Tris
ofvillus-associated enterocytes (closedarrowhead atthe topofB) .
Basolateral membrane staining is less intense. The crypt epithelial
cells contain immunoreactive ISA but at lowerlevels than villus en-
terocytes and with less prominent polarization to the apical mem-
brane (arrowhead at the bottom of the photo, 400x) . The goblet
cell denotedby the closed arrow does not appear to contain detect-
able levels of inununoreactive protein. (C) Jejunal section in-
cubatedwith anti-ISA sera that hadbeen pre-adsorbed with the pep-
tide (400x) . (D) Jejunal section incubated with preimmune sera
(400x) . (E) Section ofjejunum from thesame individual as shown
in A-D incubated with a mouse monoclonal antibody directed
against human mucins. Antigen-antibody complexes were visual-
ized using FTIC-conjugated goat anti-mouse IgG antibodies . Mu-
cus synthesizedin villusgobletcells is readily visualized . The crypt
base is denoted by the closed arrowhead (200x) . (F) Jejunal sec-
tion stained with a mouse monoclonal antibody directed against
sucrase-isomaltase . This brush border hydrolase is present at high
levels at the apical membrane of villus-associated enterocytes and
at lower levels at the apical side of crypt epithelial cells (200x) .
(G) Section of colon incubated with the anti-ISA sera . Epithelial
cells in colonic crypts contain immunoreactive protein. The intra-
cellular distribution ofISA is less polarizedthanobserved injejunal
enterocytes .Theopen arrowpoints tothesurface epithelial cuffthat
surrounds a crypt orifice . Staining of these cells appears to be
nonspecific since they are stained with preimmune sera (H, 100x) .
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Peptide sequence K
PM
Vm
%
GNRHAKAS 240 4
(human intestine-specific
annexin)
GNAAAARR 40 100'
(catalytic subunit of
bovine cAMP-dependent
protein kinase A)
GSSKSKPK 40 43$
(p6O'_")
GARASVLS 2 34t
(HIV-1 Pr55s49)
GNEASYPL 2,300 55*
(calcineurin b)(data not shown) . In contrast, control experiments demon-
strated total cellularHT29/ino cellular proteins labeled with
[3H]palmitate all had hydroxylamine-sensitive linkages (data
not shown) .
Taken together, these results suggest that ISA is a substrate
for human as well as S. cerevisiae myristoylCoA:protein
N-myristoyltransferase . The fact that both the 36- and42-kD
polypeptides are N-myristoylated with comparable efficien-
cies indicates that their amino-terminal sequences are either
very similar oridentical (as defined by their interactions with
NMT) . The dependence of ISA on its myristoyl moiety for
targeting to the enterocyte's basolateral and apical mem-
branes can be assessed by mutagenesis of its Glyz codon
and/or by metabolic labeling studies ofHT29/ino cells with
myristic acid analogues containing oxygen, or sulfur, for
methylene substitutions that produce marked reductions in
hydrophobicity yet still allow the analogue CoA to remain
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Figure 11. Metabolic labeling of proliferat-
ing HT29/ino cells with [ 3H]myristate,
[3H]palmitate, or PISImethionine . Cell
lines were labeled with [35S]methionine
(lanes 1-6), [ 3H]myristate panes 7-9), or
[ 3H]palmitate panes 10-12) as described in
Materials and Methods . Whole cell lysates
panes 1-3) or proteins recovered by immu-
noprecipitation with anti-ISA sera panes
4-12) were reduced, denatured, and sepa-
rated by SDS-PAGE . Duplicate gels were
fixed and then treated with either 1 M hy-
droxylamine (pH 10) or 1 M Tris (pH 10)
for 6 h at room temperature . The hydroxyl-
amine-treated gel is shown . The following
amounts of cellular protein were used to
generate the data shown : lanes 1-3, 1.7 Ag ;
lanes 4-6, 133 jug (before immunoprecipi-
tation) ; lanes 7-12, 267 jig (beforeimmuno-
precipitation) . Lanes 1-6and 7-14 were ex-
posed for 14 h and 17 days, respectively .
Note that (a) the intensity of ['H]palmitate
labeled bands in whole cell lysates was
markedly reduced after treatment with hy-
droxylamine compared to Tris (data not
shown ; see text) and (b) that in the Tris-
treated gel, no radiolabeled proteins were
detected after immunoprecipitation of[3H]-
palmitate-labeled HT29/ino cell lysates
(data not shown) .
substrates for NMT (Heuckeroth et al ., 1988 ; Heuckeroth
and Gordon, 1989 ; Bryant et al ., 1991 ; Kishore et al ., 1991) .
In summary, ISA appears to be distinguished from other
annexins by its extraordinarily limited cellular distribution
and by its modification by myristoylCoA:protein N-myris-
toyltransferase . ISA's precise role, ifany, in regulating intes-
tinal epithelial cell proliferation and/or differentiation re-
mains to be established . However, its patterns of expression
(a) in cultured intestinal cell lines under various culture con-
ditions and (b) along the crypt-to-villus axis ofhuman intes-
tine are consistent with such a proposed role. An analysis of
its patterns of accumulation under conditions where the in-
testinal epithelium has lost its balance of proliferation and
differentiation (e.g ., during colorectal tumorigenesis) may
offer an opportunity for further assessing its biological func-
tion as may transfection ofHT-29, CaCo-2, and SW480 cells
cultured under various conditions . Finally, the method used
419to obtain ISA from our HT29 cDNA library should be
generally useful in identifying other sequences that may
modulate the delicate balance between proliferation and
differentiation which is maintained in the dynamic, perpetu-
ally renewing, human gut epithelium.
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